Amber Myers

1 month ago | jci.org | Parham Ramezani-Rad |Ester Marina-Zárate |Laura Maiorino |Amber Myers

ResearchAIDS/HIVImmunologyOpen Access | 10.1172/JCI185292 J Clin Invest. https://doi.org/10.1172/JCI185292. Copyright © 2025, Ramezani-Rad et al. This work is licensed under the Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

Nov 6, 2024 | medium.com | Amber Myers

Amber Myers·Follow3 min read·--Today, many Christians across America are rejoicing, believing that Christ was glorified through this election. Yet the candidate who will now hold the highest office is the one who is most unlike Christ in every way possible. How do we possibly reconcile this choice with the heart of Jesus? The character and conduct of the winning candidate stand in stark contrast to the essence of Jesus. Jesus was, and is, a champion of humility and compassion.

Oct 26, 2024 | medium.com | Amber Myers

Amber Myers·Follow5 min read·--When I decided to share this journey with you all, I committed to sharing all parts of it — the highs and the lows, the victories and the struggles, and everything in between. I deeply value authenticity, so I will offer you nothing less. This past week was rough. Really rough. I was fully under attack. Less than twelve hours after posting my last entry — essentially my testimony of coming to know Jesus — Satan was hard at work trying to undo all my progress.

Oct 15, 2024 | medium.com | Amber Myers

Amber Myers·Follow2 min read·--There is so much I want to say, but I have yet to find the time or the words to give it the depth and attention it deserves. I’ve been undergoing a monumental transition — one that has transformed nearly every aspect of who I am — and I want to share every part of it with you. But putting it all on paper, articulating it in any form, has proved more daunting than I’m used to.

Aug 3, 2024 | biorxiv.org | Parham Ramezani-Rad |Ester Marina-Zárate |Laura Maiorino |Amber Myers

AbstractThe induction of durable protective immune responses is the main goal of prophylactic vaccines, and adjuvants play an important role as drivers of such responses. Despite advances in vaccine strategies, a safe and effective HIV vaccine remains a significant challenge. The use of an appropriate adjuvant is crucial to the success of HIV vaccines.